Editorial: ”AI that both impresses and frightens”

”In the past, I've rarely been particularly impressed by something that was produced by AI. But this is something completely different”, Samuel Lagercrantz writ...

Hello Jenni Nordborg!

Life Science Sweden would like to know more about Jenni Nordborg and asks her about her new job, why she became a chemical engineer and who her role model is.

Trends and overview: ELRIG "Robotics and Automation"

Laboratories on the way to end-to-end automation: Robotics, artificial intelligence and automation technology boosted by pandemic

Karolinska i Europatopp när "smartaste" sjukhusen rankas

Karolinska universitetssjukhuset i Solna är bäst i Europa på att använda ny teknik inom sjukvården, enligt en rankning i tidskriften Newsweek.

Samuel Lagercrantz: Immunotherapy against cancer is still in its early stages

with the saying: He who laughs last laughs best, writes Samuel Lagercrantz in an editorial.

The stomach medication that became the biggest blockbuster of the 1990s

The omeprazole molecule was synthesised as early as 1979, but it took many years before the then Astra had an approved pharmaceutical. Once this happened, a tab...

Hello Angelica Loskog!

Life Science Sweden would like to know more about Angelica Loskog and interviews her about her life as a researcher.

Marie Gårdmark: Finally, it’s time for a revision of the EU pharma legislation

A challenge for the EU Commission is to deliver a new framework that will also take care of another “pillar” of the pharmaceutical strategy, namely, to ensure t...

Otto Cars prisas av regeringen

Får pris för sitt mångåriga och viktiga arbete mot antibiotikaresistens.

Giulia Gaudenzi: Innovation for good

"I challenge the innovator landscape to take a mental leap. Relying on innovation-solely to end inequality is not enough, therefore consciously and purposively ...

Pilots want to live too

Mellanstor reaktor för pilotförsök

Med ett nytt flexibelt system kan man byta reaktionskärl på några minuter.

Microwave reactor for use in various synthesis applications

The Monowave 300 microwave reactor offers 850 watts of power for a variety of synthesis applications.

Saving lives worldwide with low-cost molecular diagnostics

High throughput testing for many upper respiratory tract pathogens thanks to automation technology

Alligators kandidat visar kraftfull effekt

Lundabaserade Alligator bioscience kandidat ATOR-1017 mot spridd cancer visar kraftfulla anti-tumöreffekter. Bolaget siktar på att starta studier i cancerpatienter senare i år.

Biosimilars bring price pressure, but are they sufficiently used?

When biosimilars were introduced just over 16 years ago, hopes were raised that they would give many more patients access to effective but otherwise extremely e...

Column: Why there cannot be a complete cure for cancer – but there is certainly another way!

"Is there a new way we need to be thinking about how to prevent cancer?" Lucy Robertshaw reflects upon which is the smartest way to beat cancer.

CAR-T therapies give continued hope: “Almost half of the patients have become disease-free”

become disease-free, at least of those treated with Yescarta, which are the ones I know best,” says Gunilla Enblad, Chairman of the national working group for CAR-T treatment.

Catalent löser problem i läkemedelsutveckling med expertkunskap och erfarenhet

Att arbeta med en stor utvecklingspartner som Catalent erbjuder många fördelar för små företag.

Extraherar proteiner från C.elegans

Pressure Biosciences lanserar två kit för att extrahera proteiner ur C.elegans.

Specifika antikroppar för immunoprecipitering

Med hjälp av antikroppar tillverkade av Strategic Diagnostics Inc lyckas man effektivt rena fram nativa proteiner.

Swedish and Danish Life Science – are there still untapped synergies?

With the increasing developments in life sciences over the past decade and strong support for the sector’s strategic importance from both the Sweden and Danish ...

Apple satsar på life science

Lanserar plattform för utveckling av appar som kan hjälpa forskare att samla in data och rekrytera patienter till kliniska studier.

Rekombinanta, humanproteiner från 293-celler

Origene saluför en katalog med mer än 5 000 fullängdsproteiner uttryckta i HEK 293-celler.